secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K/A
Filed at:   2024-10-09T23:59:59+00:00
Accession:  0001213900-24-086655
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.01, 3.02, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix resolves Nasdaq delisting risk via reverse split & listing approval
-----------------------------------------------------------------------------

- Received delisting notice on Sep 18 for bid price & equity non-compliance; Nasdaq approved initial listing on Sep 19, rendering issues moot.
- Effected 1-for-40 reverse stock split effective Sep 24; no fractional shares issued.
- Converted all Series A Preferred (142,749 shares) and Series B Preferred (6,741,820 shares) into common stock.
- Issued 513,424 units to Altos Venture with warrants; all warrants exercised for additional 154,027 shares.
- Post-split shares outstanding ~8.3M; common stock continues trading on Nasdaq under ONCO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390024086655/0001213900-24-086655-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390024086655/ea0217249-8ka1_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-086655

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer